Showing results (91-100 of 156) with videos related to
Sort By:
Pageof 16
Clinical Chemistry|January 23, 1999
Sensitive RIA for the specific determination of insulin lisproR R Bowsher, R A Lynch, P Brown-Augsburger, et al.Diabetologia|July 1, 1996
Difference in the influence of maternal and paternal NIDDM on pancreatic beta-cell activity and blood lipids in normoglycaemic non-diabetic adult offspringT Kasperska-Czyzyk, K Jedynasty, R R Bowsher, et al.The Journal of Pharmacology and Experimental Therapeutics|March 1, 1995
In vivo renal production and tubular secretion of tyramineJ W Van Huysse, D P Henry, L R WillisThe Journal of International Medical Research|January 24, 2002
Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hipA J Kivitz, R W Moskowitz, E Woods, et al.Southern Medical Journal|March 1, 1980
Effect of diabetes upon penile sympathetic nerves in impotent patientsA Melman, D P Henry, D L Felten, et al.The American Journal of Gastroenterology|April 24, 2001
Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritisJ L Goldstein, P Correa, W W Zhao, et al.Journal of Pharmaceutical and Biomedical Analysis|March 9, 2000
Validation of immunoassays for bioanalysis: a pharmaceutical industry perspectiveJ W Findlay, W C Smith, J W Lee, et al.Osteoarthritis and Cartilage|January 25, 2017
Identification of serological biomarker profiles associated with total joint replacement in osteoarthritis patientsR H G P Arends, M A Karsdal, K M Verburg, et al.Osteoarthritis and Cartilage|December 22, 2018
Serological biomarker profiles of rapidly progressive osteoarthritis in tanezumab-treated patientsM A Karsdal, K M Verburg, C R West, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1979
The disposition of l-3-[(dimethylamino)-(m-dioxan-5-yl)methyl]pyridine in manA Rubin, P H Dhahir, R E Crabtree, et al.Pageof 16